{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:18:48Z","timestamp":1692328728418},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.hlc.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T19:02:43Z","timestamp":1414695763000},"page":"404-406","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bleeding Risk and Incidence in Real World Percutaneous Coronary Intervention Patients with Ticagrelor"],"prefix":"10.1016","volume":"24","author":[{"given":"Ivan","family":"Subiakto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Asrar ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hlc.2014.10.006_bib0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2013.04.055","article-title":"Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes","volume":"112","author":"Berger","year":"2013","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.hlc.2014.10.006_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hlc.2014.10.006_bib0015","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ijcard.2013.06.135","article-title":"Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial","volume":"168","author":"DiNicolantonio","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2014.10.006_bib0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/HCO.0b013e3283589572","article-title":"Impact of in-hospital major bleeding on outcomes in acute coronary syndromes","volume":"27","author":"Choi","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hlc.2014.10.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2014.02.028","article-title":"Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients","author":"Gaubert","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2014.10.006_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.112.108290","article-title":"Women, bleeding, and coronary intervention","volume":"127","author":"Ahmed","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hlc.2014.10.006_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.hlc.2011.03.008","article-title":"2011 Addendum to the National Heart Foundation of Australia\/Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary Syndromes (ACS) 2006","volume":"20","author":"Chew","year":"2011","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2014.10.006_bib0040","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1440-1746.2010.06225.x","article-title":"Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study","volume":"25 Suppl 1","author":"Kawai","year":"2010","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950614007367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950614007367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T03:51:44Z","timestamp":1538106704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950614007367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1443950614007367"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2014.10.006","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding Risk and Incidence in Real World Percutaneous Coronary Intervention Patients with Ticagrelor","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}